1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Disease Outlook
3.4. Molecules Outlook
3.5. Geography Outlook
3.6. Competitor Outlook

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in prevalence of lung cancer
5.1.1.2. Rise in the number of smokers
5.1.1.3. Growing awareness regarding enhanced health care
5.1.1.4. Growing demand for lung cancer therapeutics due to increasing geriatric population
5.1.2. Restraints
5.1.2.1. Huge availability of the generic drugs
5.1.2.2. High cost of therapy
5.1.2.3. Reduced life expectancy of patients undertaking lung cancer treatment
5.1.3. Opportunities
5.1.3.1. Increasing funding in the field of research and development of new drugs
5.1.3.2. Adoption of advanced therapy such as immunotherapy
5.1.4. Challenges
5.1.4.1. Risk of side effects of radiation and chemotherapy
5.2. Cumulative Impact of COVID-19
5.3. Porters Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry

6. Lung Cancer Therapeutics Market, by Molecules
6.1. Introduction
6.2. Biologics
6.3. Small Molecules

7. Lung Cancer Therapeutics Market, by Disease
7.1. Introduction
7.2. NSCLC
7.3. SCLC

8. Americas Lung Cancer Therapeutics Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
8.6.1. California
8.6.2. Florida
8.6.3. Illinois
8.6.4. New York
8.6.5. Ohio
8.6.6. Pennsylvania
8.6.7. Texas

9. Asia-Pacific Lung Cancer Therapeutics Market
9.1. Introduction
9.2. China
9.3. India
9.4. Indonesia
9.5. Japan
9.6. Malaysia
9.7. Philippines
9.8. South Korea
9.9. Thailand

10. Europe, Middle East & Africa Lung Cancer Therapeutics Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Agennix AG
12.2. Astellas
12.3. AstraZeneca Plc
12.4. Boehringer Ingelheim GmbH
12.5. Bristol Myers Squibb
12.6. Celgene Corporation
12.7. Eli Lilly and Company
12.8. Genentech
12.9. GlaxoSmithKline plc
12.10. Hoffman-La Roche
12.11. Merck KGaA
12.12. Novartis
12.13. Pfizer
12.14. Roche
12.15. Sanofi-Aventis

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
13.3. Contact Details

List of Figures

FIGURE 1. GLOBAL LUNG CANCER THERAPEUTICS MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2020 (USD BILLION)
FIGURE 3. GLOBAL LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2020 (USD BILLION)
FIGURE 4. GLOBAL LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
FIGURE 5. GLOBAL LUNG CANCER THERAPEUTICS MARKET: MARKET DYNAMICS
FIGURE 6. GLOBAL LUNG CANCER THERAPEUTICS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 7. GLOBAL LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2020 VS 2026 (%)
FIGURE 8. GLOBAL LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2020 VS 2026 (USD BILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2026
FIGURE 10. GLOBAL LUNG CANCER THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2026 (USD BILLION)
FIGURE 11. GLOBAL LUNG CANCER THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 12. GLOBAL LUNG CANCER THERAPEUTICS MARKET SIZE, BY SMALL MOLECULES, 2018-2026 (USD BILLION)
FIGURE 13. GLOBAL LUNG CANCER THERAPEUTICS MARKET SIZE, BY SMALL MOLECULES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 14. GLOBAL LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2020 VS 2026 (%)
FIGURE 15. GLOBAL LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2020 VS 2026 (USD BILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2026
FIGURE 17. GLOBAL LUNG CANCER THERAPEUTICS MARKET SIZE, BY NSCLC, 2018-2026 (USD BILLION)
FIGURE 18. GLOBAL LUNG CANCER THERAPEUTICS MARKET SIZE, BY NSCLC, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 19. GLOBAL LUNG CANCER THERAPEUTICS MARKET SIZE, BY SCLC, 2018-2026 (USD BILLION)
FIGURE 20. GLOBAL LUNG CANCER THERAPEUTICS MARKET SIZE, BY SCLC, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 21. AMERICAS LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 22. AMERICAS LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 24. ARGENTINA LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 25. BRAZIL LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 26. CANADA LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 27. MEXICO LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 28. UNITED STATES LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 29. CALIFORNIA LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 30. FLORIDA LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 31. ILLINOIS LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 32. NEW YORK LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 33. OHIO LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 34. PENNSYLVANIA LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 35. TEXAS LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 36. ASIA-PACIFIC LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 37. ASIA-PACIFIC LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 39. CHINA LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 40. INDIA LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 41. INDONESIA LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 42. JAPAN LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 43. MALAYSIA LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 44. PHILIPPINES LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 45. SOUTH KOREA LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 46. THAILAND LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 47. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 48. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 50. FRANCE LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 51. GERMANY LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 52. ITALY LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 53. NETHERLANDS LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 54. QATAR LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 55. RUSSIA LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 56. SAUDI ARABIA LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 57. SOUTH AFRICA LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 58. SPAIN LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 59. UNITED ARAB EMIRATES LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 60. UNITED KINGDOM LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 61. GLOBAL LUNG CANCER THERAPEUTICS MARKET: FPNV POSITIONING MATRIX
FIGURE 62. GLOBAL LUNG CANCER THERAPEUTICS MARKET: MARKET SHARE ANALYSIS, BY QUADRANT
FIGURE 63. GLOBAL LUNG CANCER THERAPEUTICS MARKET: MARKET SHARE ANALYSIS, BY COMPANY
FIGURE 64. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL LUNG CANCER THERAPEUTICS MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL LUNG CANCER THERAPEUTICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 4. GLOBAL LUNG CANCER THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 5. GLOBAL LUNG CANCER THERAPEUTICS MARKET SIZE, BY SMALL MOLECULES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 6. GLOBAL LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 7. GLOBAL LUNG CANCER THERAPEUTICS MARKET SIZE, BY NSCLC, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 8. GLOBAL LUNG CANCER THERAPEUTICS MARKET SIZE, BY SCLC, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 9. AMERICAS LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 10. AMERICAS LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 11. AMERICAS LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 12. ARGENTINA LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 13. ARGENTINA LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 14. BRAZIL LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 15. BRAZIL LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 16. CANADA LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 17. CANADA LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 18. MEXICO LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 19. MEXICO LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 20. UNITED STATES LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 21. UNITED STATES LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 22. UNITED STATES LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 23. CALIFORNIA LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 24. CALIFORNIA LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 25. FLORIDA LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 26. FLORIDA LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 27. ILLINOIS LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 28. ILLINOIS LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 29. NEW YORK LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 30. NEW YORK LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 31. OHIO LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 32. OHIO LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 33. PENNSYLVANIA LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 34. PENNSYLVANIA LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 35. TEXAS LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 36. TEXAS LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 37. ASIA-PACIFIC LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 38. ASIA-PACIFIC LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 39. ASIA-PACIFIC LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 40. CHINA LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 41. CHINA LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 42. INDIA LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 43. INDIA LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 44. INDONESIA LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 45. INDONESIA LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 46. JAPAN LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 47. JAPAN LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 48. MALAYSIA LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 49. MALAYSIA LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 50. PHILIPPINES LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 51. PHILIPPINES LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 52. SOUTH KOREA LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 53. SOUTH KOREA LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 54. THAILAND LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 55. THAILAND LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 59. FRANCE LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 60. FRANCE LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 61. GERMANY LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 62. GERMANY LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 63. ITALY LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 64. ITALY LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 65. NETHERLANDS LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 66. NETHERLANDS LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 67. QATAR LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 68. QATAR LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 69. RUSSIA LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 70. RUSSIA LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 71. SAUDI ARABIA LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 72. SAUDI ARABIA LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 73. SOUTH AFRICA LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 74. SOUTH AFRICA LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 75. SPAIN LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 76. SPAIN LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 77. UNITED ARAB EMIRATES LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 78. UNITED ARAB EMIRATES LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 79. UNITED KINGDOM LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 80. UNITED KINGDOM LUNG CANCER THERAPEUTICS MARKET SIZE, BY MOLECULES, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 81. GLOBAL LUNG CANCER THERAPEUTICS MARKET: SCORES
TABLE 82. GLOBAL LUNG CANCER THERAPEUTICS MARKET: BUSINESS STRATEGY
TABLE 83. GLOBAL LUNG CANCER THERAPEUTICS MARKET: PRODUCT SATISFACTION
TABLE 84. GLOBAL LUNG CANCER THERAPEUTICS MARKET: RANKING
TABLE 85. GLOBAL LUNG CANCER THERAPEUTICS MARKET: MERGER & ACQUISITION
TABLE 86. GLOBAL LUNG CANCER THERAPEUTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 87. GLOBAL LUNG CANCER THERAPEUTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 88. GLOBAL LUNG CANCER THERAPEUTICS MARKET: INVESTMENT & FUNDING
TABLE 89. GLOBAL LUNG CANCER THERAPEUTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 90. GLOBAL LUNG CANCER THERAPEUTICS MARKET: LICENSE & PRICING
TABLE 91. GLOBAL LUNG CANCER THERAPEUTICS MARKET: CONTACT DETAILS

Companies Mentioned

Agennix AG
Astellas
AstraZeneca Plc
Boehringer Ingelheim GmbH
Bristol Myers Squibb
Celgene Corporation
Eli Lilly and Company
Genentech
GlaxoSmithKline plc
Hoffman-La Roche
Merck KGaA
Novartis
Pfizer
Roche
Sanofi-Aventis